✦ LIBER ✦

The Risk of Malignancy Associated with the Use of Biological Agents in Patients with Inflammatory Bowel Disease

✍ Scribed by Dulai, Parambir S.; Siegel, Corey A.

Book ID: 124127106
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 371 KB
Volume: 43
Category: Article
ISSN: 0889-8553
DOI: 10.1016/j.gtc.2014.05.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of biologics in inflammatory bowel d

Use of biologics in inflammatory bowel disease patients with cirrhosis

✍ Tanvi Dhere 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

Hematologic malignancies in the Japanese

Hematologic malignancies in the Japanese patients with inflammatory bowel disease

✍ Fukata, Norimasa; Okazaki, Kazuichi; Omiya, Mika; Matsushita, Mitsunobu; Watanab 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 226 KB

Risk of Solid Organ and Hematological Ma

Risk of Solid Organ and Hematological Malignancy in Patients With Inflammatory Bowel Diseases

✍ Michael Kappelman; Dóra K. Farkas; Rune Erichsen; Lars Pedersen; Robert S. Sandl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 171 KB

W1201 The Risk of Infectious Complicatio

W1201 The Risk of Infectious Complications Associated With the use of Immunosuppressive Medications in Elderly Patients With Inflammatory Bowel Disease

✍ Lin, Ming V.; Blonski, Wojciech; Aberra, Faten; Brensinger, Colleen M.; Sonu, Ir 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Risk of malignant lymphoma in patients w

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose

Risk of thromboembolic complications in

Risk of thromboembolic complications in patients with inflammatory bowel disease

✍ Maurizio Vecchi; Marco Cattaneo; Roberto de Franchis; Pier Mannuccio Mannucci 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 479 KB